Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction
Wei Zhou,1,2,* Jiachun Weng,1,* Keyan Wu,1,2,* Xiao Xu,1,* Hui Wang,1,* Jing Zhang,3,* Chengxue Zhao,1 Jie Yang,1 Yu Zhang,1,4,5 Weigan Shen1,4,5 1Department of Cell Biology, School of Medicine of Yangzhou University, Yangzhou, People’s Republic of China; 2Department of Internal Medicine,...
Main Authors: | Zhou W, Weng J, Wu K, Xu X, Wang H, Zhang J, Zhao C, Yang J, Zhang Y, Shen W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/silencing-of-taz-inhibits-the-motility-of-hepatocellular-carcinoma-cel-peer-reviewed-article-CMAR |
Similar Items
-
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01) -
Expression of cyclo-oxygenase-2 and yap/taz in hepatocellular carcinoma in untreated and treated hepatitis C virus patients
by: Dina Sweed, et al.
Published: (2022-08-01) -
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse HepatocarcinogenesisSummary
by: Haichuan Wang, et al.
Published: (2021-01-01) -
Knockdown of IL35 inhibits migration and invasion of hepatocellular carcinoma by up-regulating autophagy-related proteins in HCC cells
by: YI Yan, et al.
Published: (2023-03-01) -
Regulation of TAZ in cancer
by: Xin Zhou, et al.
Published: (2016-07-01)